COMPANY PROFILE · UPDATED 18 NOV 2025

Flare Therapeutics

Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its…

Cambridge, MA

flaretx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2021
Headcount: 73
Open roles: 0
Last raised: Series B

LEADERSHIP

Founders & key people

Steven McKnight

American biochemist and molecular biologist

UT Southwestern Medical CenterTULARIKHHMI (Howard Hughes Medical Institute)Carnegie Institution of ScienceFred Hutchinson Cancer CenterFlare TherapeuticsUniversity of VirginiaThe University of Texas at Austin

Robert Sims

Chief Officer at Flare Therapeutics

Flare TherapeuticsThird Rock VenturesConstellation PharmaceuticalsNYU School of MedicineUMDNJThe University of Texas at AustinThe University of Texas at AustinRobert Wood Johnson Medical School

Mitchell Lazar

Endocrinologist and physician-scientist

Penn's Fels Institute of GovernmentUniversity of Pennsylvania School of MedicinePerelman School of Medicine at the University of PennsylvaniaThe Wharton SchoolFlare TherapeuticsStanford University School of MedicineMassachusetts Institute of Technology (MIT)Syosset High School

Fraydoon Rastinejad

Founder at Flare Therapeutics

University of OxfordSanford Burnham Prebys Medical Discovery InstituteFlare TherapeuticsUniversity of VirginiaYale University CareersPenn's Fels Institute of GovernmentNorthwestern University